Patents
Patents for C07C 243 - Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes (2,826)
09/2009
09/30/2009EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses
09/24/2009US20090239811 Polycationic compounds and uses thereof
09/23/2009CN101541739A Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
09/17/2009US20090233913 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
09/09/2009EP1881958B1 Diacylglycerol acyltransferase inhibitors
09/03/2009US20090221712 Mandelic hydrazides
08/2009
08/27/2009WO2009103794A1 Hydrazine-modified matrices and use thereof in methods for isolating biomolecules
08/27/2009WO2009103773A1 A one-pot process for preparing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
08/27/2009WO2009103772A1 Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydrazinium)propionate esters and their use for 3-(2,2,2-trimethylhydrazinium)propionate dihydrate preparation
08/27/2009WO2009103484A1 Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
08/27/2009WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
08/27/2009CA2715675A1 Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
08/20/2009DE102008010361A1 sgk1-Inhibitoren zur Prophylaxe und/oder Therapie von viralen Erkrankungen und/oder Karzinomen sgk1-inhibitors for the prophylaxis and / or therapy of viral diseases and / or cancer
08/13/2009US20090203630 Process for preparing atazanavir bisulfate and novel forms
08/12/2009CN101506154A Compounds for treating proliferative disorders
07/2009
07/30/2009US20090192151 Therapeutic amides and related compounds
07/29/2009CN101492388A Method for synthesis of Miqujing medicament material
07/28/2009CA2399209C Process for preparation of indolopyrrolocarbazole derivative, intermediates in the preparation and process for preparation of the intermediates
07/21/2009US7563928 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
07/14/2009US7560473 Amine derivative with potassium channel regulatory function, its preparation and use
07/09/2009WO2009084229A1 Latent curing agents, epoxy resin compositions conating the same, sealing materials, and organic el displays
07/02/2009WO2009080738A1 Curable compositions having less volatilization
07/02/2009US20090170917 Acid Mimic Compounds for the Inhibition of Isoprenyl-S-Cysteinyl Methyltransferase
07/01/2009EP2074097A2 Compounds for treating proliferative disorders
06/2009
06/30/2009US7553876 angiogenesis inhibitors; a salicylamides; amphiphilic compounds; used with various antiinflammatory and cytotoxic agents as well as with radio-therapeutic agents to treat tumor growth and metastasis
06/30/2009US7553872 Compounds and compositions for delivering active agents
06/30/2009US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid
06/30/2009CA2356154C Ligands and complexes for enantioselective hydrogenation
06/25/2009US20090163592 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/24/2009EP2072550A1 Hardening compounds with reduced gas emission
06/24/2009CN100503579C Process for producing substituted aniline compound
06/17/2009EP2069290A1 Method for producing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
06/10/2009EP2067768A1 A process for the preparation of (S)(+)-3-(aminomethyl)-5-methylhexanoic acid
06/09/2009US7544838 Ligands for estrogen related receptors and methods for synthesis of said ligands
06/09/2009US7544829 Photogenerated reagents
06/04/2009US20090143615 Process for the Preparation of (S)(+)-3-(Aminomethyl)-5-Methylhexanoic Acid
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/03/2009CN100494203C Functionalized ionic liquids, and methods of use thereof
06/03/2009CA2644624A1 A process for the preparation of (s)(+)-3-(aminomethyly)-5-methylhexanoic acid
05/2009
05/28/2009WO2009065893A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same
05/28/2009CA2705662A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same
05/19/2009US7534905 2-Allyl-2-chloro-3,4-dimethyl-5-phenyl-[1,3,2]oxazasilolidinene; cyclic reagents with excellent enantioselectivities with electrophiliccompounds; carbonyl addition for optically active chiral compounds; drugs; catalysts; agriculture; stability; by-product inhibition; nontoxic; cost efficiency; in situ
05/13/2009EP2057117A2 Compounds for treating proliferative disorders
05/12/2009US7531654 Process for producing substituted aniline compound
05/06/2009EP2056106A1 Sugar chain-capturing substance and use thereof
05/06/2009EP2054465A1 Tailored control of surface properties by chemical modification
05/06/2009CN101426887A Process for the treatment of a product stream
05/06/2009CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient
04/2009
04/30/2009US20090111696 Pyridazinone Compound and Use Thereof as herbicides
04/29/2009CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
04/22/2009EP2049467A2 Therapeutic amides and related compounds
04/22/2009EP2049459A1 Novel process for the synthesis of (e)-stilbene derivatives which makes it possible to obtain resveratrol and piceatannol
04/21/2009US7521555 Such as 2-(4,6-dimethoxypyrimidine-2-ylcarbonyl)acetanilide; for use as intermediate in production of agricultural chemicals and medicines; (pyrimidine-2-yl)-2-propanonee compound reacted with hydrazine compound in the presence of an acid to produce indole compound, oxidizing, reducing, deacetylation
04/15/2009CN100478328C Process for preparing diazanyl ethyl acetate hydrochloride
04/14/2009US7517369 Dyes that are soluble in organic solvents
04/09/2009WO2008072257A3 Process for the preparation of indole derivatives
04/09/2009WO2006050120A3 Synthesis of cox-2 and faah inhibitors
04/08/2009CN101402586A Synthesis of 1-methylhydrazine
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/07/2009CA2362833C Phenylalaninol derivatives
04/02/2009WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
04/01/2009EP2042483A1 Method for manufacturing monomethyl hydrazine
04/01/2009CN101397264A Method for manufacturing monomethyl hydrazine
03/2009
03/19/2009US20090074746 Compounds to treat alzheimer's disease
03/18/2009CN101389599A Modified amino acids
03/17/2009US7504503 Process for producing substituted aniline compound
03/05/2009US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
02/2009
02/25/2009CN101374800A Mandelic hydrazides
02/18/2009EP2025665A1 Process for producing substituted aniline compound
02/12/2009US20090042961 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
02/05/2009DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases
02/03/2009US7485752 Diacylglycerol acyltransferase inhibitors
01/2009
01/27/2009US7482379 protease inhibitors more specifically to peptide inhibitors of cysteine proteases; viral infections, stroke, neurodegenerative disease, inflammatory diseases,autoimmune diseases like lupus, cancer; alpha aza-amino acid residues; prevent proteolysis
01/22/2009US20090023926 Biopolymer ionization; liquid chromatography
01/22/2009US20090023736 Compounds for treating proliferative disorders
01/14/2009EP1131337B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
01/14/2009CN101346336A 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
01/08/2009WO2009005076A1 Amide compound
01/08/2009CA2692265A1 Amide compounds
01/07/2009CN101337910A Method for preparing 3-hydrazinobenzoic acid hydrochloride
01/07/2009CN101337909A Method for preparing 2-hydrazinobenzoic acid hydrochloride
01/07/2009CN101337908A Method for preparing 2-methylphenylhydrazine hydrochloride
12/2008
12/31/2008WO2008126933A3 Process for producing pesticidal benzamide compounds
12/31/2008EP2007853A2 Process for the treatment of a product stream
12/23/2008US7468458 Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
12/23/2008US7468360 Therapeutic amides and related compounds
12/18/2008US20080308007 Method for Preparing Bitumen Base
12/18/2008CA2689137A1 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/16/2008US7465755 4-(2-{1-acetyl-2-[4-(3-chlorophenyl)-3-hydroxybutyl]hydrazino}ethyl)benzoic acid; prostaglandin EP2 and/or EP4 receptors; respiratory, inflammatory, sexual disorders, osteoporosis, ulcers; reductive amination, Michael addition, saponification
12/04/2008WO2008147765A1 Improved processes for making hydrazides
12/04/2008CA2687852A1 Improved processes for making hydrazides
12/03/2008CN100439326C Process for producing substituted aniline compound
11/2008
11/27/2008WO2008024303A3 Compounds for treating proliferative disorders
11/27/2008US20080293711 Chemokine receptor modulators
11/25/2008US7456315 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/12/2008EP1989180A1 Modified amino acids
11/05/2008CN100430371C Method for the continuous synthesis of monoalkyl-hydrazines with a functionalised alkyl group
10/2008
10/30/2008US20080269206 Cftr inhibitor compounds and uses thereof
10/30/2008US20080268537 Free of nitrone; for reducing oxidative damage or delaying senescence
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 29